Content about Lidocaine

April 18, 2014

Actavis on Friday announced that it has entered into agreements with Akorn and Hi-Tech Pharmacal to purchase four currently marketed products and one product under development for cash consideration.

DUBLIN — Actavis on Friday announced that it has entered into agreements with Akorn and Hi-Tech Pharmacal to purchase four currently marketed products and one product under development for cash consideration. The closing of the purchase agreements are contingent upon the consummation of Akorn's acquisition of Hi-Tech. Financial terms of the agreements were not disclosed.

April 15, 2014

Quest Products on Friday announced the addition of a gel formulated for emergency burn relief, Alocane Emergency Burn Gel, to its current line of products.

GURNEE, Ill. — Quest Products on Friday announced the addition of a gel formulated for emergency burn relief, Alocane Emergency Burn Gel, to its current line of products. Previously a top-selling product on retail shelves in the 80's and 90's, it was taken off the market due to financial difficulties facing the parent company, First Pharmaceutical.

February 20, 2014

Ferndale Healthcare recently announced a three-year partnership on behalf of its RectiCare (lidocaine 5%) Anorectal Cream brand and the Colon Cancer Alliance.

FERNDALE, Mich. — Ferndale Healthcare recently announced a three-year partnership on behalf of its RectiCare (lidocaine 5%) Anorectal Cream brand and the Colon Cancer Alliance. This nonprofit corporation is the nation’s leading patient advocacy organization dedicated to increasing colon cancer screening rates and survivorship.

September 16, 2013

Actavis has launched a generic drug for post-shingles pain under an agreement with the branded drug's manufacturers, the company said Monday.

PARSIPPANY, N.J. — Actavis has launched a generic drug for post-shingles pain under an agreement with the branded drug's manufacturers, the company said Monday.

Actavis announced the launch of generic lidocaine topical patches in the 5% strength under a settlement agreement with Endo Pharmaceuticals and Teikoku Seiyaku Co. The drug is a generic version of Lidoderm, and Actavis said it was likely the first company to win approval for the generic from the Food and Drug Administration, thus entitling it to 180 days in which to compete exclusively against the branded version.

September 10, 2013

Wellco Brands' debut product Healerz For Noses was selected for Walmart's Get On The Shelf contest earlier this year.

BUFFALO, N.Y. — Wellco Brands' debut product Healerz For Noses was selected for Walmart's Get On The Shelf contest earlier this year. The product is a pain relief cream targeted to soothe the delicate skin under the nose. The formula contains lidocaine for pain relief, benzalkonium chloride antiseptic to help guard against infection and aloe for its soothing properties.

August 9, 2013

Wellco Brands debut product, Healerz For Noses has been selected for Walmart’s #GetOnTheShelf contest to test the product's commercial viability.

BUFFALO, N.Y. — Wellco Brands debut product, Healerz For Noses has been selected for Walmart’s #GetOnTheShelf contest to test the product's commercial viability. To see the product video and vote, visit the "Get on the Shelf" page.

January 25, 2013

Wellco Brands on Thursday launched Healerz for Noses, a pain relief cream to soothe the skin under the nose that becomes irritated during cold and allergy season.

BUFFALO, N.Y. — Wellco Brands on Thursday launched Healerz for Noses, a pain relief cream to soothe the skin under the nose that becomes irritated during cold and allergy season.  

Healerz is formulated with lidocaine for pain relief, benzalkonium chloride antiseptic to help guard against infection and aloe for its soothing properties.  

Each package contains six single-use packets.

November 7, 2012

Absorption Pharmaceuticals recently launched Promescent, an over-the-counter lidocaine-based spray indicated for premature ejaculation.

NEWPORT BEACH, Calif. — Absorption Pharmaceuticals recently launched Promescent, an over-the-counter lidocaine-based spray indicated for premature ejaculation. The product is presently available at www.Promescent.com, through doctors’ offices and independent pharmacies. 

 Created by a urologist, the spray is designed to absorb below the surface of the skin where nerve endings that control ejaculation are located.

August 24, 2012

The Food and Drug Administration has approved a generic medicated patch for treating pain made by Watson Pharmaceuticals, the company said.

PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic medicated patch for treating pain made by Watson Pharmaceuticals, the company said.

Watson announced the approval of lidocaine topical patch in the 5% strength. The drug is a generic version of Endo Pharmaceuticals' Lidoderm, which had sales of about $1.2 billion during the 12-month period ended in June 2012, according to IMS Health.

June 6, 2012

Ferndale Healthcare on Monday announced the launch of RectiCare Anorectal cream, an over-the-counter therapy to help relieve the pain and discomfort associated with hemorrhoids.

FERNDALE, Mich. — Ferndale Healthcare on Monday announced the launch of RectiCare Anorectal cream, an over-the-counter therapy to help relieve the pain and discomfort associated with hemorrhoids. RectiCare is a topical, local anesthetic that contains 5% lidocaine.

Each tube of RectiCare comes with a supply of "finger cots," little cotton covers that fit over the finger. They promote hygienic application, since the finger doesn't come into contact with the product or the area to which it's being applied, the company stated. 

May 29, 2012

Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

PARSIPPANY, N.J. — Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.

Watson announced Tuesday a settlement through one of its subsidiaries with Endo Pharmaceuticals and Teikoku Seiyaku Co. over its generic version of Lidoderm (lidocaine) topical patch. Lidoderm had sales of $1.2 billion during the 12-month period ended in March 2012, according to IMS Health.

March 14, 2012

Endo Pharmaceuticals is hoping the Food and Drug Administration will back tougher regulatory approval requirements for generic versions of one of its drugs.

CHADDS FORD, Pa. — Endo Pharmaceuticals is hoping the Food and Drug Administration will back tougher regulatory approval requirements for generic versions of one of its drugs.

March 24, 2011

The Food and Drug Administration has approved a topical pain treatment made by Hi-Tech Pharmacal, the drug maker said Thursday.

AMITYVILLE, N.Y. — The Food and Drug Administration has approved a topical pain treatment made by Hi-Tech Pharmacal, the drug maker said Thursday.

The agency approved Hi-Tech’s sterile lidocaine jelly in the 2% strength, used for treating pain in procedures involving the urethra, painful urethritis and in endotracheal intubation.

Various versions of the drug had sales of $17 million in 2010, according to IMS Health.

January 31, 2011

Mylan has announced its intention to market a version of a painkiller made by Endo Pharmaceuticals and partner company Teikoku Seiyaku ahead of patent expiration.

CHADDS FORD, Pa. — Mylan has announced its intention to market a version of a painkiller made by Endo Pharmaceuticals and partner company Teikoku Seiyaku ahead of patent expiration.

Endo said Monday that Teikoku Seiyaku and U.S. subsidiary Teikoku Pharma USA had received a Paragraph IV certification from Mylan stating the latter’s intention to market a generic lidocaine topical patch. The drug is a generic version of Endo’s and Teikoku’s Lidoderm.

March 21, 2010

A once-a-day formulation of a Pfizer drug potentially could capture half of the market for...

January 18, 2010

Watson Pharmaceuticals has filed for regulatory approval of a generic version of a pain drug...